NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/20/2025
Back to search
Official data from USPTO
NJVCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
05/20/2025
Trademark type
Combined
Nice classes
5
Filing date
02/05/2024
Registration date
05/20/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/20/2025
Last transaction
05/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Nanjing, jiangsu, CN
Examiner
CHONG, JESSICA EUNKYO
Law office
L20
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the literal element "NJVcare" in stylized font. The literal element "NJV" stylized in color blue and the literal element "care" stylized in color white. The literal element "care" situated on a green rectangular design with rounded end corner. Aside from previously stated, the color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Holders and representatives
Holders
JIANGSU VCARE PHARMATECH CO., LTD.
Representatives
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsbiochemical drugs for diagnosing and treating tumorscardiovascular and cerebrovascular diseasesautoimmune diseasesinflammation; chemical reagents for medical or veterinary purposes; Chemical-pharmaceutical preparation for diagnosing and treating tumorscardiovascular and cerebrovascular diseasesautoimmune diseasesinflammation; Chemical preparations for pharmaceutical purposesfor diagnosing and treating tumorscardiovascular and cerebrovascular diseasesautoimmune diseasesinflammation; Medicines for human purposesfor treating tumorscardiovascular and cerebrovascular diseasesautoimmune diseasesinflammation; Drugs for medical purposespharmaceutical preparations for treating tumorscardiovascular and cerebrovascular diseasesautoimmune diseasesinflammation; Medicines made of Chinese traditional medicinal herbs; diagnostic preparations for medical purposes; pharmaceutical preparations drugs for diagnosing and treating tumorscardiovascular and cerebrovascular diseasesautoimmune diseasesinflammation
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/20/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2025
PUBO
PUBLISHED FOR OPPOSITION
04/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/26/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/06/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
12/06/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
12/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/09/2024
GNRT
NON-FINAL ACTION E-MAILED
09/09/2024
CNRT
NON-FINAL ACTION WRITTEN
09/09/2024
DOCK
ASSIGNED TO EXAMINER
08/29/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2024
NWAP
NEW APPLICATION ENTERED
02/06/2024
Continuous trademark protection
Get notified about every new filing that threatens NJVCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.